文献速递肺结节与肺癌

从不吸烟者低剂量CT筛查肺结节及侵入性诊断的结局

Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers.
PubMed 文献 · Eur Respir J · 2020-11-12

从不吸烟者活检率0.77%、肺癌检出率0.47%,均低于曾经吸烟者(1.00%、0.63%),但两组假阳性率与并发症率无显著差异。从不吸烟者肺癌中97.6%为腺癌,89.3%为I期。

要点

  • 从不吸烟者LDCT筛查肺结节阳性率16.2%,侵入性活检率0.77%。
  • 从不吸烟者肺癌检出率0.47%,低于曾经吸烟者的0.63%。
  • 两组活检假阳性率与并发症率无显著差异,吸烟与假阳性及并发症风险无关。

核心结论

  • 从不吸烟者LDCT筛查可发现值得侵入性活检的肺结节,肺癌检出率低于曾经吸烟者。
  • 从不吸烟者与曾经吸烟者活检后假阳性率及并发症率无显著差异。
  • 亚洲从不吸烟者筛查发现的结节需更特异的处理策略。

研究设计与样本

  • 比较两组结节侵入性诊断率、并发症及诊断结局。

主要发现

  • 多因素分析:吸烟与假阳性诊断风险无关(OR 0.98,95%CI 0.62-1.57),与并发症风险无关(OR 1.33,95%CI 0.65-3.73)。

临床怎么用

  • 从不吸烟者LDCT筛查可检出需活检的结节,但肺癌检出率低于曾经吸烟者。
  • 对从不吸烟者筛查结节应制定更特异的处理策略,以减少不必要活检。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although lung cancer screening using low-dose computed tomography (LDCT) is now widely used in clinical practice, the characteristics and outcomes of diagnostic procedures related to screen-detected nodules in never-smokers remain unclear. We aimed to determine the incidence of nodules considered for invasive biopsy and evaluate the final diagnoses and procedure-related complications in never-smokers in comparison to ever-smokers who underwent LDCT screening. METHODS: We evaluated 37 436 asymptomatic adults (17 968 never-smokers and 19 468 ever-smokers) who underwent LDCT screening for lung cancer between January 2009 and December 2018 at a tertiary centre in South Korea. The rates of invasive diagnostic procedures for detected nodules and related complications, and the diagnostic outcomes were determined in the never-smoker and ever-smoker groups. RESULTS: Among the never-smokers, 2908 (16.2%) out of 17 968 had positive nodules. Overall, 139 (0.77%) out of 17 968 never-smokers and 194 (1.00%) out of 19 468 ever-smokers underwent invasive biopsy (p=0.022). Lung cancer was diagnosed in 84 (0.47%) out of 17 968 never-smokers and 123 (0.63%) out of 19 468 ever-smokers (p=0.032). The proportions of participants diagnosed with benign disease after invasive biopsy (false-positive) were 50 (0.28%) out of 17 968 and 69 (0.35%) out of 19 468 in the never-smoker and ever-smoker groups, respectively (p=0.191). Multivariate analyses revealed no significant associations of smoking with the risk of a false-positive diagnosis (OR 0.98, 95% CI 0.62-1.57) and complications (OR 1.33, 95% CI 0.65-3.73) after biopsy. Of the 84 never-smokers with lung cancer, 82 (97.6%) had adenocarcinoma, and 75 (89.3%) were in stage I with a favourable prognosis. CONCLUSIONS: LDCT screening in never-smokers resulted in a notable detection rate of lung nodules, which warranted invasive biopsy. The lung cancer detection rate was lower in never-smokers than in ever-smokers. However, no significant differences in the false-positive and complication rates were observed between the two groups. Accordingly, a more specifically tailored management strategy is needed for screen-detected nodules in Asian never-smokers.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kim YW, Kang HR, Kwon BS, et al. Low-dose chest computed tomographic screening and invasive diagnosis of pulmonary nodules for lung cancer in never-smokers. Eur Respir J. 2020. PMID: 32482786. doi:10.1183/13993003.00177-2020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。